1. Home
  2. ANIP vs LZB Comparison

ANIP vs LZB Comparison

Compare ANIP & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$71.99

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

HOLD

Current Price

$31.94

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIP
LZB
Founded
2001
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
1999
1994

Fundamental Metrics

Financial Performance
Metric
ANIP
LZB
Price
$71.99
$31.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$110.00
$39.00
AVG Volume (30 Days)
397.3K
701.1K
Earning Date
05-08-2026
06-16-2026
Dividend Yield
N/A
2.75%
EPS Growth
419.23
5.11
EPS
2.32
N/A
Revenue
$206,547,000.00
$2,349,433,000.00
Revenue This Year
$21.01
$1.89
Revenue Next Year
$17.59
$2.09
P/E Ratio
$31.49
N/A
Revenue Growth
2.47
N/A
52 Week Low
$70.15
$29.03
52 Week High
$99.50
$44.90

Technical Indicators

Market Signals
Indicator
ANIP
LZB
Relative Strength Index (RSI) 38.23 30.11
Support Level $70.15 $31.76
Resistance Level $83.43 $39.96
Average True Range (ATR) 1.97 1.15
MACD -0.20 -0.40
Stochastic Oscillator 9.50 7.50

Price Performance

Historical Comparison
ANIP
LZB

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a world'wide producer of reclining chairs and one of the manufacturers/distributors of residential furniture in the United States. It manufacture, market, import, export, distribute and retail upholstery furniture products. In addition, it import, distribute and retail accessories and casegoods (wood) furniture products. Its reportable operating segments include the Retail segment and the Wholesale segment. Its Retail segment mainly sells upholstered furniture. Wholesale segment manufactures and imports upholstered and casegoods (wood) furniture and sells directly. The company generates majority of revenue from Wholesale segment which manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, etc.

Share on Social Networks: